Section Arrow
ANL.NASDAQ
- Adlai Nortye Ltd
Quotes are at least 15-min delayed:2026/02/09 16:13 EST
After Hours
Last
 10.11
-0.01 (-0.10%)
Bid
9.97
Ask
10.11
High 10.12 
Low 10.0965 
Volume 34 
Regular Hours (Closed)
Last
 10.12
+0.11 (+1.10%)
Day High 
10.7699 
Prev. Close
10.01 
1-M High
12.0899 
Volume 
172.11K 
Bid
9.97
Ask
10.11
Day Low
9.84 
Open
10 
1-M Low
1.35 
Market Cap 
369.37M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 7.63 
20-SMA 4.73 
50-SMA 2.74 
52-W High 12.0899 
52-W Low 0.8786 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-1.14/-1.08
Enterprise Value
369.80M
Balance Sheet
Book Value Per Share
0.21
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
5.00M
Operating Revenue Per Share
--
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
LIMNLiminatus Pharma Inc1.435-0.405-22.01%-- 
After Hours 1.35 -- --
HUMAHumacyte1.205+0.2667+28.42%-- 
After Hours 1.23 -- --
IBRXImmunityBio6.97+0.92+15.21%-- 
After Hours 7.06 -- --
ROIVRoivant Sciences Ltd27.67+1.85+7.16%1.95PE
After Hours 27.67 0 0.00%
GERNGeron Corp1.605+0.075+4.90%-- 
After Hours 1.61 -- --
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Adlai Nortye Ltd is a clinical-stage biotechnology company focused on the discovery and development of cancer therapies for patients across the spectrum of tumor types. The company has a robust pipeline of drug candidates which includes buparlisib (AN2025), palupiprant (AN0025), and AN4005 in the clinical stage, and AN8025, AN9025, and AN1025 in the preclinical stage.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.